| # | Drug | Count |
|---|---|---|
| 0 | RUXOLITINIB | 131 |
| 1 | ASPIRIN | 91 |
| 2 | ASPIRIN 325 MG | 91 |
| 3 | ASPIRIN 81 MG | 91 |
| 4 | HYDROXYUREA | 57 |
| 5 | ADALIMUMAB | 33 |
| 6 | OMEPRAZOLE MAGNESIUM | 28 |
| 7 | ERGOCALCIFEROL | 27 |
| 8 | TESTOSTERONE | 27 |
| 9 | ALLOPURINOL | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | 1.85% HYDROCORTISONE ACETATE - 1.15% PRAMOXINE HCI CREAM | 1 | 0.3333 |
| 1 | BEVACIZUMAB-ADCD | 2 | 0.0099 |
| 2 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 3 | OLSALAZINE SODIUM | 1 | 0.0051 |
| 4 | CLOMIPHENE CITRATE | 6 | 0.0040 |
| 5 | ANAGRELIDE HYDROCHLORIDE | 4 | 0.0034 |
| 6 | HYDROXYUREA | 57 | 0.0027 |
| 7 | BALSALAZIDE DISODIUM | 1 | 0.0019 |
| 8 | ETHACRYNIC ACID | 1 | 0.0018 |
| 9 | RUXOLITINIB | 131 | 0.0018 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 148 |
| 1 | Janus Kinase Inhibitor [EPC] | 134 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 116 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 91 |
| 4 | Antimetabolite [EPC] | 57 |
| 5 | Corticosteroid [EPC] | 43 |
| 6 | Proton Pump Inhibitor [EPC] | 37 |
| 7 | Tumor Necrosis Factor Blocker [EPC] | 36 |
| 8 | Factor Xa Inhibitor [EPC] | 33 |
| 9 | Loop Diuretic [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interferon alfa-2b [EPC] | 3 | 0.0016 |
| 1 | Interleukin-6 Antagonist [EPC] | 1 | 0.0015 |
| 2 | Isocitrate Dehydrogenase 1 Inhibitor [EPC] | 3 | 0.0014 |
| 3 | Androgen [EPC] | 29 | 0.0011 |
| 4 | Provitamin D2 Compound [EPC] | 27 | 0.0009 |
| 5 | Janus Kinase Inhibitor [EPC] | 134 | 0.0008 |
| 6 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 7 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 9 | Interleukin-17 Receptor A Antagonist [EPC] | 1 | 0.0005 |